오늘의 이슈
전체 보도
FDA panel recommends easing restrictions on several peptides, including BPC-157
23건·16개 매체·4개국
진보 성향 40%중도 성향 47%보수 성향 13%
6개 매체7개 매체2개 매체
관련 개체STAT
진영별 관점 대조
같은 사건을 세 진영이 어떻게 다르게 규정하는지 — ONP가 정리한 프레임입니다.
전체 보도23건
Inside the unconventional FDA panel that could reshape the peptide industry
🇺🇸 Business Insider진보 성향US panel backs trendy peptides despite safety concerns
🇦🇪 Gulf News중도 성향US panel backs trendy peptides despite safety concerns
🇸🇬 The Straits Times World보수 성향WATCH LIVE: Day 2 of FDA advisory panel meeting to consider use of peptides
🇺🇸 PBS NewsHour중도 성향FDA advisory panel recommends loosening restrictions on 2 unapproved peptides
🇺🇸 CBS News진보 성향An FDA Panel Just Endorsed These Unproven Peptides
🇺🇸 Wired중도 성향FDA panel recommends easing restrictions on several peptides, including BPC-157
🇺🇸 NBC News Top Stories진보 성향FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists
🇺🇸 The Hill중도 성향FDA panel recommends controversial treatments
🇺🇸 NBC News Top Stories진보 성향FDA panel loosens restrictions for controversial peptides popular online
🇬🇧 BBC News중도 성향US health panel recommends easing restrictions on controversial peptides
🇬🇧 The Guardian World진보 성향FDA considers widening access to peptides promoted by wellness influencers
🇺🇸 PBS NewsHour중도 성향What's the deal with peptides? The hyped market under US review
🇬🇧 Medical XpressSTAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
🇺🇸 STAT News중도 성향FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list
🇺🇸 ABC News (US)진보 성향FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
🇺🇸 Washington Times보수 성향FDA considers green-lighting unproven peptide injections boosted by RFK Jr as scientists issue warnings
🇬🇧 The Independent (World)진보 성향FDA panel to consider loosening regulations for some peptides
🇺🇸 CBS News진보 성향FDA panel confronting peptide controversy
🇺🇸 STAT News중도 성향Demand for unapproved peptides soars as influencers tout unproven health benefits
🇺🇸 CBS News진보 성향WATCH LIVE: FDA advisory panel considers use of peptides
🇺🇸 PBS NewsHour중도 성향The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.
🇺🇸 MarketWatch중도 성향Health experts issue caution over unapproved peptides as FDA weighs easing restrictions
🇺🇸 CBS News진보 성향